View Older Stories

Mar 24, 2020 08:30AM ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL

Mar 2, 2020 08:31AM ANI Pharma (ANIP) Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules

Mar 2, 2020 08:30AM ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules

Feb 27, 2020 08:30AM ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020

Feb 12, 2020 08:30AM ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL

Jan 24, 2020 08:30AM ANI Announces Launch of Tolterodine Extended-Release Capsules

Jan 16, 2020 08:32AM ANI Pharma (ANIP) Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP

Jan 16, 2020 08:30AM ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP

Jan 14, 2020 08:30AM ANI Announces Launch of Paliperidone Extended-Release Tablets

Jan 9, 2020 08:32AM ANI Pharma (ANIP) Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals

Jan 9, 2020 08:30AM ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.

Dec 18, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL

Nov 26, 2019 08:30AM ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference

Nov 6, 2019 08:30AM ANI Pharmaceuticals Reports Third Quarter Results

Oct 31, 2019 08:30AM ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias

Oct 29, 2019 08:30AM ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business

Oct 3, 2019 08:31AM ANI Pharma (ANIP) Reports Positive Clinical Results from Cortrophin Gel Cortisol Response Study

Oct 3, 2019 08:30AM ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study

Oct 2, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg

Sep 11, 2019 08:32AM ANI Pharma (ANIP) Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

Sep 11, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

Aug 7, 2019 08:30AM ANI Pharmaceuticals Reports Second Quarter Results

Jun 25, 2019 08:35AM ANI Pharma (ANIP) Announces Launch of Ranitidine Capsules

Jun 25, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Ranitidine Capsules

Jun 20, 2019 10:33AM ANI Pharma (ANIP) Announces FDA Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

Jun 20, 2019 10:30AM ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

Jun 18, 2019 08:03AM ANI Pharma (ANIP) Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis

Jun 18, 2019 08:00AM ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.

Jun 12, 2019 08:30AM ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference

May 9, 2019 08:30AM ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance

Apr 15, 2019 08:38AM ANI Pharma (ANIP) Expands Injectable Portfolio with Distribution Agreement

Apr 15, 2019 08:30AM ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product

Mar 27, 2019 08:34AM ANI Pharma (ANIP) Announces Two Generic Product Launches

Mar 27, 2019 08:30AM ANI Pharmaceuticals Announces Two Generic Product Launches

Feb 27, 2019 08:30AM ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance

Dec 27, 2018 04:30PM ANI Pharmaceuticals Secures Refinancing for Convertible Debt Due December 2019 and Enters Amended Five-Year $265 Million Senior Secured Credit Facility

Dec 7, 2018 08:00AM ANI Pharmaceuticals Enters into Separate Privately Negotiated Agreements with Certain Holders of its Convertible Notes

Nov 6, 2018 08:30AM ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance

Oct 16, 2018 09:00AM ANI Announces Launch of Authorized Generic of Brethine®

Oct 4, 2018 08:33AM ANI Pharma (ANIP) Announces Launch of Authorized Generic of Atacand HCT Tablets

Oct 4, 2018 08:30AM ANI Pharmaceuticals Announces Launch of Authorized Generic of Atacand HCT® Tablets

Sep 27, 2018 08:30AM ANI Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

Aug 8, 2018 01:00PM ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference

Aug 7, 2018 08:30AM ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

Aug 6, 2018 08:30AM ANI Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference

Jun 27, 2018 08:06AM ANI Pharma (ANIP) Reports Launch of Cholestyramine for Oral Suspension USP

Jun 27, 2018 08:00AM ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP

Jun 5, 2018 08:37AM ANI Pharma (ANIP) Appoints Thomas J. Haughey, David B. Nash and Patrick D. Walsh to Board

Jun 5, 2018 08:30AM ANI Shareholders Elect Three New Members to the Board of Directors

May 8, 2018 08:30AM ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance

View Older Stories